NTII Neurobiological Technologies (MM)

EMERYVILLE, Calif., May 4 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NASDAQ:NTII), (NTI(R)) today announced that Paul E. Freiman, President and Chief Executive Officer will present at the BIO 2007 Business Forum in Boston on May 7 at 4 p.m. in room B. The BIO conference is being held May 7-9, 2007, at the Boston Convention and Exhibition Center. To access the presentation, please visit the following link: http://www.shareholder.com/ntii/medialist.cfm The BIO Business Forum highlights growth companies in the life science industry. Companies share their clinical strategy and insights into new development and opportunities in the industry to an audience of institutional investors, hedge funds, bankers and private equity investors. About Neurobiological Technologies, Inc. NTI is a biotechnology company engaged in the business of acquiring and developing central nervous system related drug candidates. The Company is focused on therapies for neurological conditions that occur in connection with ischemic stroke and brain cancer. The Company's strategy is to in-license and develop later-stage drug candidates that target major medical needs and that can be rapidly commercialized. NTI's experienced management team oversees the human clinical trials necessary to establish preliminary evidence of efficacy. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Craig W. Carlson, VP & CFO of Neurobiological Technologies, Inc., +1-510-595-6000 Web site: http://www.ntii.com/

Copyright